Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gregson

Showing results (61-70 of 129) with videos related to

Pageof 13
Sort By:
AJNR. American Journal of Neuroradiology|July 26, 2014
Treatment of poor-grade subarachnoid hemorrhage trialD Mitra, B Gregson, V Jayakrishnan, et al.
The Journal of Hospital Infection|October 12, 2004
Intensive-care-unit-acquired bloodstream infections in a regional critically ill populationK B Laupland, A W Kirkpatrick, D L Church, et al.
Journal of Clinical Microbiology|December 14, 2011
Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian regionGisele Peirano, Akke K van der Bij, Daniel B Gregson, et al.
Human Pathology|November 30, 2010
Immunoglobulin A-dominant postinfectious glomerulonephritis: frequent occurrence in nondiabetic patients with Staphylococcus aureus infectionSuchin Worawichawong, Louis Girard, Kiril Trpkov, et al.
The Pediatric Infectious Disease Journal|January 1, 2009
The changing burden of pediatric bloodstream infections in Calgary, Canada, 2000-2006Kevin B Laupland, Daniel B Gregson, Otto G Vanderkooi, et al.
Infection|December 17, 2009
Population-based study of the epidemiology and the risk factors for Pseudomonas aeruginosa bloodstream infectionM D Parkins, D B Gregson, J D D Pitout, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|August 25, 2007
Investigation of sources of potential bias in laboratory surveillance for anti-microbial resistanceKevin B Laupland, Terry Ross, Johann D D Pitout, et al.
International Journal of Antimicrobial Agents|August 15, 2008
Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactamJohann D D Pitout, Phillip Le, Deirdre L Church, et al.
Antimicrobial Agents and Chemotherapy|April 15, 2009
Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health RegionJohann D D Pitout, Lorraine Campbell, Deirdre L Church, et al.
BMC Public Health|July 11, 2019
Sociodemographic and geospatial associations with community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections in a large Canadian city: an 11 year retrospective studyVictoria C Gill, Irene Ma, Maggie Guo, et al.
Pageof 13

Showing results (61-70 of 129) with videos related to

Sort By:
Pageof 13
AJNR. American Journal of Neuroradiology|July 26, 2014
Treatment of poor-grade subarachnoid hemorrhage trialD Mitra, B Gregson, V Jayakrishnan, et al.
The Journal of Hospital Infection|October 12, 2004
Intensive-care-unit-acquired bloodstream infections in a regional critically ill populationK B Laupland, A W Kirkpatrick, D L Church, et al.
Journal of Clinical Microbiology|December 14, 2011
Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian regionGisele Peirano, Akke K van der Bij, Daniel B Gregson, et al.
Human Pathology|November 30, 2010
Immunoglobulin A-dominant postinfectious glomerulonephritis: frequent occurrence in nondiabetic patients with Staphylococcus aureus infectionSuchin Worawichawong, Louis Girard, Kiril Trpkov, et al.
The Pediatric Infectious Disease Journal|January 1, 2009
The changing burden of pediatric bloodstream infections in Calgary, Canada, 2000-2006Kevin B Laupland, Daniel B Gregson, Otto G Vanderkooi, et al.
Infection|December 17, 2009
Population-based study of the epidemiology and the risk factors for Pseudomonas aeruginosa bloodstream infectionM D Parkins, D B Gregson, J D D Pitout, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|August 25, 2007
Investigation of sources of potential bias in laboratory surveillance for anti-microbial resistanceKevin B Laupland, Terry Ross, Johann D D Pitout, et al.
International Journal of Antimicrobial Agents|August 15, 2008
Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactamJohann D D Pitout, Phillip Le, Deirdre L Church, et al.
Antimicrobial Agents and Chemotherapy|April 15, 2009
Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health RegionJohann D D Pitout, Lorraine Campbell, Deirdre L Church, et al.
BMC Public Health|July 11, 2019
Sociodemographic and geospatial associations with community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections in a large Canadian city: an 11 year retrospective studyVictoria C Gill, Irene Ma, Maggie Guo, et al.
Pageof 13